Forbes |
Allergan Agrees To 9 A Share Actavis Takeover Over Bill Ackman-Backed …
Forbes Botox-maker Allergan AGN +5.23% has agreed to be sold to generic pharmaceutical manufacturer Actavis Actavis for 9 a share in cash and stock, in a move that counters a long-running hostile takeover campaign led by Valeant Pharmaceuticals Valeant … No Allergan Deal, but a .6 Billion Profit for Ackman Actavis to buy Botox-maker Allergan for B Allergan-Actavis deal follows battle for soul of pharma |